Sobre la Empresa
- Nombre legal: Beijing Kawin Technology Share-Holding Co.,Ltd
- País de registro: China
- Dirección: No.6 Rongjing East Street, BDA, Beijing, China, Beijing
- Número de empleados: 500 - 999
Descripción:
Focused on viral and immune diseases, Kawin offers mature products built on its specialty in interferon strain management to EP standards, and provides product licensing opportunities including a portfolio of glycyrrhizin products used in dermatology and hepatology, with transfer of interferon and G-CSF (both conventional and pegylated) open to discussion.
Actividades Comerciales
Productos Biofarmacéuticos
Fabricante de Principios Activos (API)
Servicios Biofarmacéuticos
Fabricante de Principios Activos (API)
Clasificación ATC (Anatómica, Terapéutica, Química)
Fabricante de Principios Activos (API)
Mercados de Venta
- East Asia: China, Democratic People's Republic of Korea, Mongolia, Republic of Korea, Japan, Taiwan
- South Asia: Bangladesh, Bhutan, India, Maldives, Nepal, Pakistan, Sri Lanka, Afghanistan, Iran
- Mainland Southeast Asia: Cambodia, Lao People's Democratic Republic, Myanmar, Thailand, Viet Nam, Brunei Darussalam, Indonesia, Malaysia, Philippines, Timor-Leste, Singapore
- Western Asia: United Arab Emirates, Armenia, Azerbaijan, Bahrain
Productos/Servicios Clave
Nuestros Productos & Servicios
Certifications
Proofs
CPHI & PMEC China 2026
06/2026 – 06/2026
CPHI & PMEC China 2026
Calificaciones
(0)
(0)
(0)
(0)
(0)
Comentarios
Filtros:
Ordenar por:
No hay comentarios disponibles.
Deja tu valoración & comentario